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Abstract: Orellanine (OR) toxin is produced by mushrooms of the genus Cortinarius which grow in
North America and in Europe. OR poisoning is characterized by severe oliguric acute renal failure,
with a mortality rate of 10%–30%. Diagnosis of OR poisoning currently hinges on a history of ingestion
of Cortinarius mushrooms and histopathology of renal biopsies. A key step in the diagnostic approach
is analysis of tissues for OR. Currently, tissue-based analytical methods for OR are nonspecific and
lack sensitivity. The objectives of this study were: (1) to develop definitive HPLC and LC-MS/MS
tissue-based analytical methods for OR; and (2) to investigate toxicological effects of OR in mice. The
HPLC limit of quantitation was 10 µg/g. For fortification levels of 15 µg/g to 50 µg/g OR in kidney,
the relative standard deviation was between 1.3% and 9.8%, and accuracy was within 1.5% to 7.1%.
A matrix-matched calibration curve was reproduced in this range with a correlation coefficient (r)
of 0.97–0.99. The limit of detection was 20 ng/g for LC-MS/MS. In OR-injected mice, kidney OR
concentrations were 97 ˘ 51 µg/g on Day 0 and 17 ˘ 1 µg/g on termination Day 3. Splenic and liver
injuries were novel findings in this mouse model. The new tissue-based analytical tests will improve
diagnosis of OR poisoning, while the mouse model has yielded new data advancing knowledge on
OR-induced pathology. The new tissue-based analytical tests will improve diagnosis of OR poisoning,
while the mouse model has yielded new data advancing knowledge on OR-induced pathology.
Keywords: orellanine; Cortinarius mushrooms; renal failure; analytical method; diagnosis; liver
injury; HPLC; LC-MS/MS
1. Introduction
Orellanine is a potent natural bipyridyl toxin produced by Cortinarius mushrooms, which grow
throughout Europe and parts of North America. Cortinarius orellanus and C. rubellus are the major
orellanine-containing mushrooms which are responsible for causing human intoxications. In these
mushrooms, orellanine occurs mainly in form of its mono- and diglucoside [1].
The toxicity of Cortinarius mushrooms was first recognized in 1957 in Poland [2]. About 102
individuals were intoxicated by ingesting C. orellanus, 10% of whom died [2,3]. Acute renal failure
(ARF) is the major presentation of Cortinarius human mushroom poisoning, but liver injury has also
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been reported [2,4]. Recently C. orellanosus was reported to have been responsible for a case of human
poisoning in Michigan [5].
Acute renal failure typically develops 7–14 days post ingestion of the poisonous mushrooms,
but can occur as early as 3 days after. The hepato-renal syndrome reported in some human cases is
characterized by increased serum liver enzymes and bilirubin [6]. Histologically, human lesions include
tubulo-interstitial nephritis and liver cellular necrosis and lipidosis [2]. Other clinical signs reported in
Cortinarius mushroom intoxications include headache, gastrointestinal distress and neuromuscular
symptoms such as limb paresthesia and myalgia [6]. In veterinary medicine, the first case of Cortinarius
mushroom poisoning in animals was reported in sheep [7]. The disease, which was confirmed by
feeding the mushrooms to sheep, was characterized by hypocalcemia, hyponatremia, proteinuria, and
hemoglobinuria. Grossly, petechial hemorrhages in the skin, subcutis, and epicardium were observed
while tubulointerstitial nephritis was seen histologically [7]. There are many other toxin-induced
causes of ARF in humans and in animals, including arsenic, inorganic mercury, cadmium and lead;
natural toxins such as ochratoxins, aflatoxins, and citrinin; medications; and other mushroom species
such as Amanita smithiana [8–10]. Therefore, the diagnosis of Cortinarius mushroom intoxication cannot
be made on the basis of clinical presentation alone.
A conclusive diagnosis of any human and animal intoxication rests on many pillars, including
a history consistent with presence of toxin in the environment or food; clinical signs consistent with
the suspect toxin; a complete blood cell count (CBC) and a comprehensive serum chemistry and
urinalysis profile; gross and histological findings consistent with the suspect toxin; and especially
analytical confirmation of the presence of the toxin and/or its metabolites in biological fluids and
tissues. Identification and quantitation of OR in tissues is a critical step in forensic and clinical
diagnostic investigations of Cortinarius mushroom intoxication.
A comprehensive review of the literature revealed a lack of suitable definitive tissue-based
analytical test methods for quantifying OR in tissues. Existing tissue-based analytical tests are difficult
to perform; most are based on outdated technologies like thin layer chromatography (TLC) and
electrophoresis which are riddled with false positives and false negatives, and lack sensitivity and
selectivity. This poses challenges to forensic and diagnostic communities because the use of such
procedures is likely to yield unreliable results with false conclusions.
Rapior et al. used TLC to analyze for OR and its breakdown product orelline in human renal
biopsies [11]. TLC is nonspecific because it is subject to cross reactivity with non-target molecules.
Results were reported as OR “equivalents” using unconventional units. Orellanine “equivalent”
concentrations in renal biopsies were reported as 7 µg/25 mm3 on Day 13 post ingestion of mushrooms
and 24 µg/8 mm3 at 6 months post ingestion. These results are difficult to translate to conventional
units, such as parts-per-million or µg/g commonly used for forensic toxicological and diagnostic
interpretations. Rohrmoser et al. also used TLC to analyze human body fluids, dialysis fluids, and
kidney biopsies for OR and orelline [12]. Kidney OR concentration was reported as 160 ng/µL
and 35 ng/µL for samples taken on a few days apart [12]. These unconventional units, ng/µL
for tissues, provide challenges in interpretation of toxicological data. Rohrmoser et al. [12] also
questioned the validity of results of one study by Andary et al. [13], who analyzed renal biopsies
using high performance liquid chromatography (HPLC) and TLC techniques. HPLC and TLC are not
confirmatory procedures.
Holmdahl et al. [14] did preliminary studies of OR analysis in serum and kidney using HPLC
equipped with an electrochemical detector. In developing their serum and kidney assay they spiked
serum and kidneys of untreated mice with OR. Orellanine added to serum was completely recovered,
but the recoveries of the kidney spikes were very poor, at only 25%. These investigators did not report
any serum or kidney OR concentration in their animal toxicity studies, but reported results of OR in
mushrooms only. For the kidney, they reported histopathology results only and no quantitative OR
data was reported [14]. Another limitation of their mouse study was the lack of CBC, urinalysis data,
and the histopathology of other organs [14].
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Herrmann et al. developed a method based on quadrupole time-of-flight mass spectrometry/mass
spectrometry (QTOF-MS/MS) for analysis of OR in blood and mushroom stew [15]. An extensive
description of extraction of OR from the mushroom was provided. Studies of rat blood spiked with
OR recovered 60% of the added OR. The limitation of that comprehensive study was that the method
for kidney OR analysis was not described [15]. Since the kidney is a more complex matrix than serum,
the serum method cannot be directly transferred to analyze the kidney without further optimization.
This is because OR is known to be tightly bound in the kidney and extraction from the kidney is more
complex than in serum or mushrooms [12]. The OR in the kidney is reportedly insoluble and cannot be
removed by dialysis [12]. A second limitation of their study was that they did not extend their method
to analyze tissues or serum from animals naturally intoxicated or experimentally dosed with either
OR or Cortinarius mushrooms. Thus the performance of the method for detection of OR in animals
naturally poisoned by Cortinarius mushrooms could not be evaluated.
On the basis of this background, it was apparent that more research on tissue-based analytical test
methods for forensic purposes and diagnosis of OR intoxications in humans and animals was needed.
We therefore conducted this study with two specific objectives: (1) to develop definitive quantitative
HPLC and liquid chromatography/mass spectrometry (LC-MS/MS) tissue-based analytical methods
for OR and (2) to investigate morphological, blood and serum biochemical changes, urine changes,
and multiple organ histological changes in mice injected with OR. We chose to work with mice because
there are few studies in this species and also due to the limited amount of OR we had at hand, the
small size of the mouse was appealing.
Overall, the value of this study was to improve the diagnosis of OR poisoning in humans and
animals using tissue-based diagnostic tests, CBC and clinical chemistry, histopathology, and urinalysis
using a less commonly used animal model, the mouse.
2. Results
2.1. Clinical Observations
Negative control mice injected with saline did not exhibit any clinical signs during the course of
the study. However, mice given OR exhibited clinical signs starting 24 h after OR injections, but clinical
signs became more prominent after 48 h. One mouse from the OR-treated group was euthanized 72 h
after OR dose because it was moribund. The most significant clinical observations in OR-dosed mice
included loss of appetite, lethargy, loss in body weight, and oliguria. The OR-dosed mice also looked
dehydrated as evidenced by changes in skin elasticity. Changes in body weight are shown in Figure 1,
while changes in urine output on the day before the 96 h euthanasia is shown in Figure 2. On Day 4
(96 h), most OR-dosed mice exhibited piloerection and appeared rounded, were ataxic when mobile
and were most often sedentary.
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i re 1. Change in body weight in mice given orellanine comp und to those given 0.9% normal saline.
Orellanine c used a significant reduction in body weight compared to controls (p < 0.01).
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orellanine compared to controls (** p < 0.01). 
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Figure 2. Total urine volume in mice given orellanine or 0.9% normal saline. Represents five mice
per group over 12 h before euthanasia at 96 h. Urine output was significantly reduced in mice given
orellanine compared to controls (** p < 0.01).
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Table 1. Organ weight changes in mice given orellanine compound with control group given 0.9%
normal saline.
Organ Weights Orellanine
Hours after Intoxication
Control (n = 12) 2 (n = 12) 24 (n = 12) 96 (n = 8)
Lung (mg) 167.4 ˘33.8 129.7 ˘ 37.5 * 151.0 ˘ 21.8 139.8 ˘ 29.1
Spleen (mg) 66.0 ˘ 15.2 67.5 ˘ 8.9 46.6 ˘ 11.7 27.7 ˘ 10.8 †
Liver (mg) 1203.3 ˘ 138.7 961.7 ˘ 342.0 * 922.8 ˘ 168.6 † 892.3 ˘ 124.6 †
Kidney (mg) 297.2 ˘ 23.9 302.9 ˘ 42.1 288.3 ˘ 26.75 273.7 ˘ 20.2
Note that orellanine caused a statistically significant reduction in lung, splenic, and liver weights compared
to the controls. Values given are means ˘ 1 standard deviation. * p < 0.05 compared to controls; † p < 0.01
compared to controls.
2.3. CBC and Serum Chemistry Profile Results
Changes in CBC are summarized in Table 2. Although there were no statistically significant
changes in total white blood cell counts, OR caused a significant increase in total neutrophil counts and
a statistically significant reduction in total lymphocyte and eosinophil counts. The neutrophilia was
noticeable starting 24 h post OR exposure, whereas lymphopenia and eosinophilia were immediate,
starting at 2 h post-OR exposure. Orellanine also caused a significant reduction in total platelet counts.
Platelet counts were reduced by about 71% from a control mean 1161 ˆ 103/µL to about 333 ˆ 103/µL,
96 h post OR exposure. There were no statistically significant changes in total red blood cell counts,
total hemoglobin, or hematocrit, but OR caused a statistically significant reduction in mean corpuscular
volume (MCV) and a statistically significant increase in mean corpuscular hemoglobin concentration
(MCHC) 96 h post OR-exposure. Presence of nucleated red blood cells (RBC) was observed, but only
at 96 h post OR exposure.
A summary of serum biochemical changes in OR-treated mice is provided in Table 3.
Unfortunately, because most OR-dosed mice were dehydrated at the 96 h time point, sufficient
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blood to run for all tests was obtained from 3 mice only. There was a statistically significant increase
in blood urea nitrogen (BUN), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) 96 h
post OR exposure. These serum results suggest there were both renal and hepatic injuries in mice
injected with OR. Although there were no statistically significant changes in total serum protein, serum
albumin concentration was significantly reduced at 2 and 24 h post-OR exposure. However, serum
albumin concentration appeared to rebound to normal range at 96 h. Serum electrolyte changes in mice
given OR were characterized by hypocalcemia, reduced sodium ion concentration, and a significant
elevation in serum phosphorus concentration (Table 3).
With regard to urinalysis results, unfortunately because of oliguria, we were only able to perform
qualitative tests because of inadequate urine sample volume which precluded extensive urinalysis
testing. Urine from OR dosed mice tested positive for hematuria and proteinuria (2+) and was slightly
acidic with a pH in the range of 5.5–7.0. On the contrary, urine from control mice tested negative for
blood, and proteins and the pH was in the 7.0–8.0 range. Urine from OR dosed mice was pale yellow
while that of controls was yellow. There was no change in urine specific gravity.
Table 2. Total and differential blood cell counts in mice given orellanine compared to control group
given 0.9% normal saline.
Complete Blood Count Orellanine
Hours after Intoxication
Control (n = 4) 2 (n = 5) 24 (n = 5) 96 (n = 3)
White blood cells (103/µL) 5.9˘ 2.0 3.6˘ 0.5 4.8˘ 1.3 3.8˘ 1.1
Red blood cells (103/µL) 8.9˘ 1.3 8.6˘ 0.2 9.8˘ 1.0 10.3˘ 0.9
Neutrophils (103/µL) 0.6˘ 0.3 0.9˘ 0.5 2.4˘ 1.4 * 2.7˘ 0.9 *
Monocytes (103/µL) 0.1˘ 0.1 0.1˘ 0.1 0.1˘ 0.1 0.1˘ 0.1
Lymphocytes (103/µL) 5.2˘ 1.1 2.7˘ 0.4 † 2.3˘ 0.7 † 1.1˘ 0.8 †
Eosinophils (103/µL) 0.2˘ 0.1 0.0˘ 0.0 * 0.0˘ 0.0 * 0.0˘ 0.0 *
Platelets (103/µL) 1161.3˘ 110.2 989.8˘ 163.0 1092.0˘ 110.1 333.0˘ 258.8 †
Hemoglobin (gm/dL) 14.0˘ 1.1 13.0˘ 0.2 14.6˘ 1.7 16.0˘ 1.0
Hematocrit (%) 48.5˘ 3. 44.9˘ 2.0 49.7˘ 5.5 48.7˘ 5.3
Mean corpuscular volume (MCV) (fL) 52.9˘ 1.0 52.5˘ 3.0 50.7˘ 1.3 47.1˘ 1.6 †
Mean corpuscular hemoglobin (pg) 15.3˘ 0.21 15.2˘ 0.2 14.9˘ 0.2 15.5˘ 0.5
Mean corpuscular hemoglobin concentration
(MCHC) (gm/dL) 28.9˘ 0.3 28.9˘ 1.1 29.4˘ 0.7 32.9˘ 2.1 *
Red blood cell (RBC) distribution width (%) 12.9˘ 1.1 13.0˘ 0.5 12.7˘ 0.3 12.5˘ 0.9
Mean platelet volume (fL) 4.5˘ 0.2 5.2˘ 1.1 4.4˘ 0.1 7.2˘ 3.7
Note that orellanine caused a statistically significant increase in total neutrophil count and mean corpuscular
hemoglobin concentration, and reduced the total lymphocyte, eosinophil, and platelet counts. Values given are
means ˘ 1 standard deviation. * p < 0.05 compared to controls; † p < 0.01 compared to controls.
Table 3. Serum chemistry profile in mice injected with orellanine compared to control group given
0.9% normal saline.
Serum Clinical Parameters
Orellanine
Hours after Intoxication
Control (n = 11) 2 (n = 11) 24 (n = 10) 96 (n = 3)
Alanine aminotransferase (IU/L) 38.1˘ 10.1 53.1˘ 20.2 62.8˘ 37.4 164.3˘ 219.0 †
Blood urea nitrogen (mg/dL) 17.9˘ 5.2 16.3˘ 5.5 50.0˘ 51.2 77.3˘ 89.3 †
Alkaline phosphatase (IU/L) 101.5˘ 10.3 105.3˘ 14.3 136.2˘ 37.3 183.7˘ 162.3 *
Albumin (gm/dL) 4.2˘ 0.2 3.5˘ 0.3 2.8˘ 1.0 † 3.7˘ 1.6
Calcium (mg/dL) 11.3˘ 0.4 9.7˘ 1.4 7.7˘ 1.2 † 10.2˘ 3.8
Glucose (mg/dL) 274.4˘ 45.1 174.1˘ 78.9 186.9˘ 120.0 352.3˘ 269.8
Phosphorus (mg/dL) 8.4˘ 1.2 10.6˘ 1.9 11.9˘ 3.9 * 8.8˘ 3.8
Potassium (mEq/L) 7.7˘ 0.5 8.1˘ 0.5 8.4˘ 0.3 8.4˘ 3.7
Sodium (mEq/L) 158.5˘ 7.1 156.5˘ 4.9 158.7˘ 7.3 137.0˘ 15.4 †
Total bilirubin (mg/dL) 0.6˘ 0.8 0.3˘ 0.0 0.3˘ 0.0 0.3˘ 0.2
Creatinine (mg/dL) 0.2˘ 0.1 0.2˘ 0.0 0.4˘ 0.3 0.4˘ 0.4
Total Protein (gm/dL) 5.7˘ 0.3 4.9˘ 0.3 5.4˘ 0.9 5.9˘ 2.3
Note that orellanine caused significant elevations in serum alanine aminotransferase (ALT), blood urea nitrogen
(BUN), alkaline phosphatase (ALP), and phosphorus levels. Orellanine also caused a reduction in serum
albumin, calcium, and sodium. Values given are means ˘ standard deviation. * p < 0.05 compared to controls;
† p < 0.01 compared to controls.
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2.4. Histopathology Results
Significant lesions were observed in the renal cortex of all examined OR treated mice and included
variable degeneration and necrosis of the tubular epithelium with regeneration, tubular ectasia, and
tubular proteinosis (Figure 3A). Affected tubules often contained low numbers of sloughed epithelial
cells. The renal tubules of control mice were unremarkable (Figure 3B). The spleens of OR treated
mice were smaller with reduced overall cellularity relative to control mice (Figure 3C,D) and the white
pulp of OR treated mice was characterized by moderate to high numbers (10%–50%) of pyknotic and
karyorrhectic lymphocytes (Figure 3E,F). Moderate random hepatocellular vacuolation was observed
in one OR-treated mouse (Figure 4). Lesions were also observed in the stomachs of mice given OR
and included presence of neutrophils within the lamina propria of the non-glandular stomach with
variable associated thickening of the squamous epithelium and submucosal edema; however, low
numbers of neutrophils were also occasionally observed in the lamina propria of control mice at the
junction of the glandular and non-glandular stomach.
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Figure 3. Representative  images  from mice  treated with orellanine  (OR) or saline controls  (CON). 
Hematoxylin and eosin. (A) (top left) Kidney from an OR‐treated mouse revealing variable tubular 
degeneration and ectasia with luminal accumulations of proteinic fluid and occasional sloughed cells; 
(B) (top right) kidney from a CON mouse with normal tubular morphology; (C) (middle left) spleen 
from  an OR‐treated mouse  revealing  an  overall  reduction  in  red  and white pulp  cellularity;  (D) 
(middle right) spleen  from a CON mouse with normal cellularity and well‐defined red and white 
pulp margins;  (E)  (bottom  left)  higher magnification  of white  pulp  from  an  OR‐treated mouse 
revealing  numerous  pyknotic  and  karyorrhectic  lymphocytes  (arrows);  (F)  (bottom  right)  higher 
magnification of white pulp  from a CON mouse with normal morphology. Scales: A,B,E,F = 600× 
magnification; C,D = 100× magnification. 
epresentative i ages fro ice treated ith ore lanine ( R) or saline controls ( ).
t li i . ( ) (t l ft) i -
ti and ectasia with lumin l accumulations of proteinic flui and occ sional sloughed
cells; (B) (top right) kidney from a CON mouse with normal tubular m rphology; (C) (middle left)
spleen from an OR-treated mouse revealing an ov rall reduction in red and white pulp cellularity;
(D) (middle right) spleen from a CON mouse with normal cellularity and well-defined red and it
l argins; (E) (bottom left) hig er magnification of white pulp from an OR-treated mouse revealing
numerous pyknotic and karyorrhectic l mp ocytes (arrows); (F) (bottom right) higher magnification
of white pulp from a CON mouse with normal morphology. Scales: A,B,E,F = 600ˆ magnification;
C,D = 100ˆ magnification.
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Table 4. A summary of calibration curves established by fortified kidney tissues, range, regression 
equation, and linearity using HPLC *. 
Run  Fortification Levels, μg/g Equation Linearity (R2) 
1  15, 20, 30, 40, 50  y = 1.81x − 7.15  0.97 
2  10, 15, 20, 25, 30, 35, 40, 50  y = 1.85x − 3.72  0.99 
3  10, 15, 20, 25, 30, 35, 40, 50  y = 1.85x − 1.78  0.99 
* High performance liquid chromatography. 
Comparing the nominal concentrations from all three calibration curves, we calculated the inter‐
day repeatability in terms of relative standard deviation (RSD), as shown in Table 5. The RSD varied 
from 1.3%–9.8% for OR tissue concentration range of 15–50 μg/g, indicating the good repeatability of 
the  method.  Accuracy  was  reported  as  the  relative  difference  between  the  back‐calculated 
concentration and fortification levels. The results were between 1.5% and 7.1% for the range of 15–50 
μg/g. Therefore these results supported the validity of the calibration curves and sample preparation 
procedure. 
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2.5. HPLC Method Validation and Analysis of OR
HPLC chromatographs of OR were shown in Figure 5 for an OR-treated mouse kidney. Results
of mouse kidneys fortified at different concentrations of OR, are shown in Table 4. Three calibration
curves were established on three separate runs. Mouse kidney samples were fortified with OR at
concentrations in the range of 10–50 µg/g. This analytical range was chosen because it is clinically
relevant. In human OR intoxication cases, kidney biopsy OR concentrations were found to be in the
range of 35–160 µg/mL [12]. The correlation coefficients (r) were excellent and generally above 0.99
except for the first one which was 0.97. The method limit of quantitation (LOQ) was 10 µg/g.
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Figure 5. (From top to bottom) HPLC chromatographs of orellanine in an orellanine-exposed
mouse kidney (Day 0), an orellanine-spiked control mouse kidney (25 µg/g), and a negative control
mouse kidney.
Table 4. A summary of calibration curves established by fortified kidney tissues, range, regression
equation, and linearity using HPLC *.
Run Fortification Levels, µg/g Equation Linearity (R2)
1 15, 20, 30, 40, 50 y = 1.81x ´ 7.15 0.97
2 10 15, 20, 25, 30, 35, 40, 50 y = 1.85x ´ 3.72 0.99
3 10, 15, 20, 25, 30, 35, 40, 50 y = 1.85x ´ 1.78 0.99
* High performance liquid chromatography.
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Comparing the nominal concentrations from all three calibration curves, we calculated the
inter-day repeatability in terms of relative standard deviation (RSD), as shown in Table 5. The
RSD varied from 1.3%–9.8% for OR tissue concentration range of 15–50 µg/g, indicating the
good repeatability of the method. Accuracy was reported as the relative difference between the
back-calculated concentration and fortification levels. The results were between 1.5% and 7.1% for
the range of 15–50 µg/g. Therefore these results supported the validity of the calibration curves and
sample preparation procedure.
Table 5. A summary of inter-run repeatability (RSD *) and accuracy of fortified kidney tissues
using HPLC †.
Fortification Levels, µg/g RSD *, % Average Nominal Concentration ‡, µg/g Accuracy §, %
15.0 6.4 14.5 3.3
20.0 9.8 18.6 7.1
30.0 5.6 31.6 5.2
40.0 1.3 40.8 2.1
50.0 2.3 49.2 1.5
* Relative standard deviation. It is based on three analyses. † High performance liquid chromatography.
‡ Nominal concentration is back-calculated from the calibration curve using the response of peak area from
HPLC analysis. The average nominal concentration is calculated based on three analyses for each fortification
level. § Accuracy is calculated as (Average nominal concentration-fortification level)/fortification level ˆ 100%.
It indicates the closeness of the concentration quantified by the calibration curve to the fortification level.
Following validation of the HPLC method, we proceeded to analyze the kidneys of mice injected
subcutaneously (SC) with OR for presence of OR. The results are shown in Table 6. Orellanine was only
found in the kidneys of mice given OR. The highest OR concentration (97 ˘ 51 µg/g) was found 2 h
post OR-exposure. The kidney OR concentration gradually declined, but was still present when the
experiment was terminated at 96 h post OR exposure (17 ˘ 1 µg/g).
Table 6. A summary of orellanine kidney concentrations by HPLC in given orellanine and euthanized
over different times (2 h, 24 h, and 96 h post exposure). The results are reported in the format of
“mean ˘ standard deviation”.
Time after Exposure, h Orellanine Concentration, µg/g
2 97 ˘ 51
24 45 ˘ 34
96 17 ˘ 1
Control Below LOQ (<10 µg/g)
n = 6 for each time intervals (2 h, 24 h, and 96 h) and the control group.
2.6. Results for Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS)
Evaluation of the LC-MS/MS method for kidneys showed an average OR recovery of 91%.
The LOD was 20 ng/g. We then proceeded to analyze kidneys for presence of OR. Representative
chromatographs of OR in solvent (upper graph) and from renal tissue of mice exposed in vivo (lower
graph) are shown in Figure 6. Orellanine was only found in the kidneys of mice given OR. LC-MS/MS
results give a confirmatory response for the presence of OR in the kidney tissue. This demonstration of
OR using triple quadrupole LC-MS/MS using incurred OR in tissue shows definitive confirmation
over spiked samples shown by Herrmann et al. [15].
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3. Discussion
There is a substantial body of published literature on Cortinarius mushroom poisoning in humans
in Europe and North America which is partly covered in reviews [6,16]. Cortinarius mushroom
poisoning has also been reported in animals [7]. Orellanine is the active nephrotoxin in
Cortinarius mushrooms [1,17].
A comprehensive review of the literature revealed that a complete toxicity profile of
Cortinarius mushrooms has not yet been established. A comprehensive toxicity profile is essential for
proper diagnosis and treatment of OR poisoning. Most rodent studies to-date have been narrow in
scope, more or less focusing on renal effects of Cortinarius mushroom intoxications [3]. Another related
challenge is that most rodent studies were conducted with rats, yet some reports suggest rats are not
very sensitive to OR poisoning [3]. The few studies that utilized mice were limited in scope, and the
kidney, other organs such as the immune system, the liver, and lungs were not examined histologically.
In this study, we took a comprehensive approach to understand the toxicity of OR in mice. Results
confirm that the kidney is a target organ of OR poisoning as shown by histological changes of proximal
tubular necrosis and supporting serum chemistry profiles, indicative of ARF, including elevated BUN
and serum phosphorus. Although there was no statistically significant increase in serum creatinine, the
trend in this acute short term study was one of increased serum creatinine at the time the study was
terminated at 96 h. However, this is the first report of renal weight in animals experimentally dosed
with OR or Cortinarius mushrooms. It is interesting that there were no significant changes in renal
weight of mice given OR. Frequently, intoxications leading to ARF, such as that caused by mercuric
chloride, are characterized by increased renal weight [9]. Renal weight increase is often associated
with interstitial edema, which was not observed in the present study.
The proteinuria and hematuria observed in these mice is likely of tubular origin because
histopathology showed tubular necrosis. Urine of mice given OR was acidic, but the cause of this is
not clear. However, because mice were anorexic, it is probable that ketosis contributed to low urine pH
observed in mice in this study. Ketonuria should be evaluated in future studies.
This comprehensive OR mouse study has demonstrated that other organs besides the kidney
are affected. In particular, liver injury was demonstrated by reduced liver weight, elevated liver
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enzymes, and histopathology characterized by mild hepatocellular vacuolation. This finding is
consistent with reported hepato-renal syndrome in some human cases of Cortinarius mushroom
intoxication [17]. The reasons for reduced liver weight are unknown. A possible hypothesis is that
mobilization of glycogen and or/lipids because of anorexia caused reduced liver weight. Of particular
note, hepatotoxicity has not been reported in rats, the most widely used rodent model of OR or
Cortinarius mushroom intoxication. This is interesting because it is suggested in the literature that
rats are more resistant to OR poisoning than humans [3]. It is possible that interspecies differences
in sensitivity to OR exist and that mice are more sensitive to OR than rats and thus a more suitable
animal model for human disease.
A novel finding revealed by the present study is splenic atrophy, characterized by lymphocytolysis.
We also observed significant changes in white blood cell counts including neutrophilia, lymphopenia
and eosinopenia. Whether these leukocyte changes can be explained by stress and corticosteroid
induced immunosuppression remains to be determined in future studies.
Another interesting observation from this study was thrombocytopenia. Thrombocytopenia
may cause hemorrhage. Overås et al. reported petechial hemorrhages in the skin, subcutis and
subepicardially in lambs poisoned after natural ingestion of Cortinarius mushrooms [7]. Unfortunately,
a CBC was not reported in that case report. It is also interesting however that Overås et al., like in the
present study, also reported a pronounced hypocalcemia and hyponatremia in sheep which presumably
died of C. speciosissimus poisoning [7]. These results underscore the importance of including a CBC as
part of a clinical evaluation of humans and animals suspected to have ingested Cortinarius mushrooms.
Hematological changes consistent with those reported here are suggestive of Cortinarius mushroom
poisoning. This is particularly important in veterinary medicine where history of mushroom ingestion
is sometimes vague and incomplete.
Gastrointestinal effects are among the earliest effects noted in human victims of OR poisoning.
These include abdominal pain, vomiting, and diarrhea which may revert to constipation. These effects
appear 2–3 days post ingestion and there is no explanation given regarding their origin. In this study,
gastrointestinal effects were seen in mice even though OR exposure was by SC injection. Mice given
OR had bloated stomachs and the fecal content in the lower small intestines and in the large intestines
were dark, suggestive of melena. However, histopathology of the gastrointestinal tract (GIT) did not
reveal epithelial necrosis and the reason for dark feces presently is unknown. The only histological
changes noted in the GIT were in the stomach and were characterized by neutrophil infiltration of
lamina propria of the glandular stomach. Unlike bloating which was present in all OR-dosed mice,
these lesions were not universally present and the significance of these finding remains unclear at the
present time.
The limitations of currently published methods for analysis of OR in tissues were presented in the
introduction. We now have developed tissue-based diagnostic analytical test methods for diagnosis
of OR poisoning. We chose the kidney as a sample of choice based on case reports in the human
literature suggesting the kidney is the ideal specimen for diagnosis of OR poisoning for up to 60
days after clinical signs of OR poisoning manifest [12]. A reliable, sensitive, and quantitative HPLC
method for quantitation of OR has been established in our laboratory. We have used this method to
quantify OR, the biomarker of Cortinarius mushroom intoxication in kidneys of mice dosed with OR.
Our results have shown that in mice dosed with a toxic dose of OR approximating the mouse LD50, the
concentration of OR in the kidney was a mean of about 97 µg/g (parts-per-million, ppm) soon after
injection, but it declined to a mean of 17 ppm 96 h post-injection. This represents an 82% reduction
in kidney orellanine concentration over 96 h. In this study, we only analyzed for orellanine but not
orelline, which has been reported in studies using TLC [12]. Our results suggest that the concentration
of OR substantially declines in the kidney over a 48 h time period, perhaps due to metabolism and/or
elimination through urine. Orellanine has not been found in urine after 48 h in some human case
reports [12].
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To be absolutely certain that we were specifically measuring OR, we established a confirmatory
LC-MS/MS analytical test for OR. As expected, the LC-MS/MS method was more sensitive than the
HPLC method. The LC-MS/MS is specific for OR because it detects specific daughter ions of the parent
OR compound. We recommend using HPLC for routine analysis and the LC-MS/MS for unequivocal
confirmation of the presence OR in the kidney. Results of this study showed that the HPLC method is
sensitive enough to detect diagnostically relevant kidney OR concentrations which are expected to
be > 10 ppm (10 µg/g tissue), which have been reported for human cases [12]. The other advantage is
that HPLC is also commonly available in most diagnostic laboratories compared to LC-MS/MS. Our
veterinary diagnostic laboratory is the only laboratory to have established tissue-based diagnostic tests
for OR in the North America. Using these diagnostic tests, we have shown that OR is present only in
the kidneys of mice given OR. Orellanine was not present in control mice. Our results also show that
kidney OR concentrations > 10 ppm are diagnostic of OR poisoning.
4. Experimental Section
4.1. Animal Studies
The primary objective of the animal study was to expose mice to OR in vivo and collect biological
samples from OR-dosed and control mice for diagnosis of OR poisoning. This was not primarily
a study of OR toxicity in mice, but rather the objective was to use tissues and fluids from exposed
animals to develop a comprehensive diagnostic profile of OR poisoning in the mouse. All animal
studies were approved by the Iowa State University Institutional Animal Care and Use Committee
(IACUC) (4-12-7341-M, 30 March 2014). The C57/BL6 (6–7 weeks) male mice used in these studies
were purchased from The Jackson Laboratories (Bar Harbor, ME, USA). They were housed 4 per cage
in the Laboratory Animal Resource (LAR) Facility of the Iowa State University College of Veterinary
Medicine (ISU CVM). The cage contained environmental enrichment appropriate for mice. The mice
were acclimated for 1 week to a room temperature of 20–21 ˝C, relative humidity of 35%–50% and
a 12 h light cycle. Light automatically turned on at 6 AM and turned off at 6 PM. They were provided
14% Protein Rodent maintenance diet (Teklad Global, Harlan Sprague Daley Inc., Indianapolis, IN,
USA) and drinking water ad libitum. Environmental enrichment in the form of toys appropriate for
mice were provided 24/7.
Mice were randomly assigned to one of the following two study groups, 12 mice per group:
A negative control group of mice received 0.9% normal saline at 20 mL/kg body weight (bw)
subcutaneously (SC) on Day 0; test mice were injected 20 mg/kg bw OR SC on Day 0. Subsets
of mice given OR were euthanized 2 h, 24 h, or 96 h after OR injection. The OR dosage was selected
basing on intraperitoneal (IP) LD50 values reported for mice [6]. The objective was to use a dosage that
would certainly cause nephrotoxicity in mice so that we could sufficiently evaluate diagnostic criteria
for OR intoxication in mice. We chose the SC over the IP route because the former is less invasive.
Also, given the limited supply of OR at hand, we preferred the SC route over oral administration, as
the IP route would require more toxin. Ultimately, the SC route of administration did not impact the
primary objective of the study, which was to expose mice to OR and collect biological samples from
OR-dosed and control mice for diagnosis of OR poisoning.
Injectable OR solution was prepared by dissolving 3 mg of OR in 150 µL pyridine (Sigma Aldrich,
St. Louis, MO, USA) and bringing the total volume to 3mL with 0.9% normal saline. The final amount
of pyridine in the injected solution was only 5%. In order to minimize the number of mice for this
study, negative control mice injected with 0.9% normal saline were euthanized at 96 h, the same time
point as the longest held OR dosed mice in this study.
Mice were weighed on Day 0 prior to treatment, and daily thereafter until euthanasia. Mice
were examined daily and any observed clinical signs were recorded. Pooled urine was collected
from four test mice and four negative control mice placed in wire bottom cages over a 12 h time
period, starting immediately after dosing on Day 0 and on the day before euthanasia. The urine was
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collected from the bottom of plastic cages every 3 h during the 12 h collection period using a syringe to
avoid evaporation. Urine volume was determined using a graduated syringe. Urine samples were
refrigerated before submission for urinalysis testing in the Clinical Pathology Laboratory of the Iowa
State University College of Veterinary Medicine (ISU CVM). Urinalysis was done qualitatively using
manual dipsticks, visually for color, or microscopically for sediments. Parameters evaluated included
color, transparency, specific gravity, glucose, bilirubin, ketones, blood, pH, protein, casts, white and
red blood cells, crystals, bacteria, and presence of epithelial cells. Unfortunately, the sample size of
urine collected from dehydrated OR-dosed mice precluded analysis of urine for OR.
Mice designated for a CBC were euthanized using carbon dioxide by inhalation. Blood was
collected from the heart using an 18 gauge needle and either placed in ethylenediaminetetraacetic
acid (EDTA) tubes for a CBC or in non-anticoagulated red top tubes, allowed to clot, and then
centrifuged to collect serum for serum chemistry profile analysis. Both the CBC (n = 5/group) and
serum chemistry profiles (n = 11/group) were performed in the Clinical Pathology Laboratory, ISU
CVM. The hematology and CBC were performed on a hematology system and the serum chemistry
profile was run on an Abaxis analyzer (VetScand, Abaxis, Union City, CA, USA). The hematology
consisted of total and differential while blood cell counts. The serum chemistry profile included total
protein, albumin, alkaline phosphatase (ALP), alanine transferase (ALT), amylase, total bilirubin, blood
urea nitrogen (BUN), calcium, phosphorus, creatinine, glucose, sodium, and potassium. Unfortunately,
serum sample volume was insufficient, which precluded running OR.
Various tissues including the kidneys, liver, spleen, and lungs were collected, weighed, and
either frozen at ´80 ˝C until analysis for OR analysis. We chose the kidney (n = 6) for OR
analysis because it is the primary target organ and is the sample of choice for OR analysis [12].
Mice designated for histopathology (n = 3 per group) were anesthetized with a ketamine/xylazine
combination (90 mg/10 mg)/kg IP. Once anesthetized, the thoracic cavity was opened to expose the
heart. Phosphate buffered saline (PBS) (Sigma Aldrich, St. Louis, MO, USA) was injected through the
left heart ventricle followed by 4% paraformaldehyde (Sigma Aldrich, St. Louis, MO, USA). Upon
full perfusion, samples collected for histologic examination included lung, liver, kidney, spleen, heart,
stomach, duodenum, jejunum, ileum, cecum, and colon. Samples were placed in 10% neutral-buffered
formalin for at least 24 h, embedded in paraffin, sectioned at 4 µm and processed routinely for
hematoxylin and eosin (H&E) staining.
4.2. Chemicals and Reagents for Chromatography Analysis of OR
HPLC-grade methanol, HPLC-grade acetonitrile, concentrated hydrochloric acid, ammonium
hydroxide, ammonium acetate, o-phosphoric acid (85%), formic acid, and 0.45 µm nylon syringe
filters were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Orellanine standard (95%)
and for animal experiments was purchased from Ramidus AB (Lund, Scania, Sweden). All aqueous
solutions were prepared in 18.2 MΩ¨ cm water (Aries Filter Network, West Berlin, NJ, USA). Bond
Elut Jr mycotoxin columns (Agilent Technologies, Santa Clara, CA, USA) were purchased for clean-up
columns. A 3M hydrochloric acid solution was prepared by adding 24.9 mL concentrated hydrochloric
acid into pure water and bringing the volume to 100 mL with water. A 3M hydrochloric acid in
methanol solution was prepared by adding 24.9 mL concentrated hydrochloric acid into HPLC-grade
methanol and bringing the volume to 100 mL by methanol. A 4 mM ammonium acetate aqueous
solution was prepared by dissolving 0.308 g ammonium acetate in pure water and bringing the volume
to 1 L. A 1% formic acid aqueous solution was prepared by diluting 5 mL formic acid to a total volume
of 500 mL with water. Orellanine standards were prepared by dissolving corresponding amounts of
OR pure standard in hydrochloric acid solution (pH 1.5). Because OR is known to photodegrade, the
OR standards were stored in aluminum-foil-wrapped vials for protection from light.
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4.3. Sample Preparation for OR Analysis by HPLC
We focused on analyzing the kidney because published literature of intoxication in humans
suggests it is the tissue of choice for OR testing [12]. Whereas OR was not detectable in serum and urine
after onset of symptoms, it was detectable in renal biopsies taken 60 days after onset of intoxication [12].
We chose to include HPLC in our study because this analytical platform is commonly available in many
veterinary diagnostic toxicology laboratories. To start, an in-house HPLC method was developed to
analyze for OR in the kidney. The tissue sample preparation procedure was a significant modification
from a method reported by Herrmann et al. [15]. As indicated in the introduction, the limitations
of Herrmann [15] study were: their method focused on analysis of mushrooms; kidney OR analysis
was not described; the mushroom method was not applied to analysis of tissues or serum derived
from animals dosed either with OR or Cortinarius mushrooms; and they used QTOF-MS/MS, an
expensive platform found only in a few diagnostic laboratories. As described, the method was not
ideal for analysis of OR in the kidney. Three major changes were made: (a) A clean-up step was
added to further remove the interferences from OR. This cleanup step gave good selectivity for OR.
(b) We discovered that the pH of mobile phases was critical in stabilizing OR in the HPLC analysis, we
replaced formic acid with o-phosphoric acid because the latter is less volatile and is able to maintain
the pH for an extended period of time. (c) A more time-efficient extraction step combining vortex
mixing and sonication was introduced, to replace the original 3-h extraction procedure for mushrooms.
These major changes tailored to kidney extraction yielded good selectivity and sensitivity.
Briefly, approximately 0.1 g mouse tissue was homogenized in 4 mL 3M hydrochloric acid in a
vortex mixer for 5 min at 2500 rpm. The mixture was then sonicated for 20 min at room temperature,
followed by centrifugation at 3000 rpm (1744ˆ g) for 30 min. The supernatant was neutralized
with 1 mL ammonium hydroxide to adjust to the optimum pH for clean-up, and then loaded onto
clean-up columns. After washing the columns with 20 mL pure water followed by 20 mL methanol
(both adjusted to pH 1.5 with formic acid), the OR was eluted with 5 mL 3M hydrochloric acid in
methanol at a flow rate of 10–20 mL/min. The eluent was concentrated to 0.2 mL under nitrogen.
4.4. HPLC Conditions
Measurements were performed with an HPLC system equipped with a Chromeleon program for
the system manipulation, data acquisition and analysis, a photodiode array UV-Vis detector (Ultimate
3000 HPLC, Dionex, Thermo Fisher, Waltham, MA, USA), and a C18 HPLC column purchased from
Agilent (PLRP-S C18 column, 3 µm, 150 mm ˆ 4.6 mm, Agilent Technologies, Santa Clara, CA, USA).
The mobile phase consisting of 4 mM ammonium acetate aqueous solution (A) and methanol (B) [15]
was pumped at a flow rate of 0.3 mL¨min´1. Both mobile phases were adjusted to pH 1.5 with
o-phosphoric acid. A gradient elution was used to give an optimum separation. Details of the gradient
elution program are summarized in Table 7. A total run time of 20 min was used. The injection
volume was 50 µL. The separation was performed at room temperature. Orellanine was detected
spectroscopically at a wavelength of 308 nm.
Table 7. A summary of HPLC * gradient for orellanine analysis.
Time, min 4 mM Ammonium Acetate Aqueous Solution (A), % Methanol (B), %
0–2.0 98 2
2.0–4.0 15 85
4.0–20.0 15 85
* High performance liquid chromatography.
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4.5. Sample Preparation for Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Analysis
We developed a liquid chromatography tandem mass spectrometry for only definitive
confirmation of the identity of OR in tissues. The sample preparation procedure was modified
from the QTOF-MS/MS procedure of analysis of OR in mushrooms [15]. Briefly, 0.1 g mouse tissue
was extracted in 400 µL methanol: 3 M hydrochloric acid solution (10:1, v/v), followed by vortexing
for 1 min and centrifugation at 20,000ˆ g for 5 min. As in the Hermann et al. paper of extracting OR
from mushrooms [15], we found acid was essential for extracting the OR from tissues giving better
recoveries with than without addition of acid. Orellanine stock standard was prepared by weighing
2 mg of orellanine and dissolving in 2 mL of 3M HCL to create a 1000 µg/g standard. Orellanine
working standards for use on LC-MS/MS were prepare by diluting the stock standard in methanol:
3M hydrochloric acid (10:1, v/v) to obtain a 1 µg/g standard.
4.6. LC-MS/MS Conditions
Analyses were performed using a triple-quadrupole LC-MS/MS (Varian 310 LC-MS/MS system,
Agilent Technologies, Santa Clara, CA, USA) with an electrospray ionization (ESI) chamber in the
positive mode, an autosampler (410 Varian Prostar autosampler, Agilent Technologies, Santa Clara,
CA, USA) and two HPLC pumps (210 Varian Prostar HPLC pump, Agilent Technologies, Santa Clara,
CA, USA) Needle voltage was ´3000 V, collision induced dissociation gas pressure 0.20 Pa, drying
gas temperature was 150 ˝C, nebulizer gas pressure was 3.45 ˆ 105 Pa, drying gas pressure
was 6.89 ˆ 104 Pa, detector was biased at 1500 V, acquisition time was 10 min. The mobile phase
consisted of solvent A: 1% formic acid, and solvent B: acetonitrile, at an isocratic elution with a ratio of
5:95, v/v) [15]. The mobile phase was modified from a paper by Hermann et al. [15] for use with PRP-1
column (Hamilton PRP-1 column 10 µm, 250 ˆ 4.1 mm I.D. part# 79427, Phenomenex, Torrance, CA,
USA). This column is well suited for the low pH of the extract and performs well. The flow rate was
0.4 mL/min. Orellanine was detected by LC-ESI-MRM using transition modes 253 > 163, 253 > 191,
253 > 219, 253 > 236 obtained by infusion of orellanine. Multiple transitions for this compound assist
in confirmation. These transitions were similar to those used for QTOF-MS/MS procedure. This is
an improvement because by expanding LC-MS/MS use to triple quadrupole for the OR compound
allows greater capabilities for use of LC-MS/MS instrumentation for confirmation and quantification.
The detailed parameters of the quadrupole mass spectrometers are listed in Table 8. A 20 µL
sample was injected into the column.
Table 8. A summary of LC-ESI-MRM * conditions for orellanine analysis.
Q1, m/z Q3, m/z Capillary Voltage, V Collision Voltage, V Dwell Time, ms
253 163 36 20 0.5
253 191 36 25.5 0.5
253 219 36 20 0.5
253 236 36 14 0.5
* Liquid chromatography-triple quad mass spectrometry, electrospray ionization, multiple reaction monitoring.
4.7. Statistical Analysis
Statistical analysis to detect differences between the control group of mice injected with 0.9%
normal saline and the OR treated mice was performed using a commercially available statistics package
(GraphPad Software, Inc., La Jolla, CA, USA). Endpoints measured and statistically analyzed included
animal body weight; organ weights including liver, kidney, and spleen; urine volume; complete blood
cell counts and differentials; and serum enzymes. A one-way analysis of variance (ANOVA) was
performed followed by a Dunnett’s post-test for comparison of the means of each group for each end
point to that of controls. A p value of less than 0.05 was considered statistically significant.
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5. Conclusions
In conclusion, this study has moved research on diagnosis of Cortinarius mushroom-induced
toxicity forward. We have developed definitive tissue-based analytical test methods for detection,
quantitation and confirmation of OR, a biomarker of Cortinarius mushroom poisoning. The HPLC LOQ
was 10 ppm while the LC-MS/MS LOD was 20 ppb. Mice intoxicated with OR contained an average
of 17 ppm OR 96 h post OR injection. Besides the kidney, the study showed that the liver is also affected
by OR. Splenic lymphocytolysis and reduced splenic weight were notable findings reported for the
first time. OR-induced serum biochemical changes included elevated BUN, ALT, and phosphorus
and decreased serum calcium, sodium, and albumin. Orellanine caused thrombocytopenia, while the
leukogram was characterized by elevated neutrophils and significantly decreased lymphocytes and
eosinophils. Collectively, these findings will be beneficial to clinicians and diagnosticians in reaching a
conclusive diagnosis of OR poisoning in animals.
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